About Plas-free

About company

PlasFree focuses on the development of ClearPlasma, a medical device that modifies human plasma to improve treatment for massive bleeding. ClearPlasma extracts fibrinolytic proteins that are responsible for dissolving blood clots. It modifies the human plasma generating improved plasma that is more prone to coagulation. PlasFree's product aims to revolutionize the treatment of massive bleeding and to enable safe and effective treatment to massive bleeding around the world. PlasFree was founded in 2017 and is headquartered in Nazareth, Israel.